☆ 4.7 Article

Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome

Andrea Dressing et al.

Summary: During the long-term phase after COVID-19 infection, patients may experience cognitive deficits and fatigue. In this study, cognitive testing and brain glucose metabolism imaging showed minor impairments in cognitive domains and no distinct pathological changes. This differs from previous findings in subacute COVID-19 patients and may be related to the high prevalence of fatigue.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review

Philipp T. Meyer et al.

Summary: This study systematically reviewed the current literature on how COVID-19 affects the human brain using molecular imaging techniques like PET and SPECT. The findings include reversible metabolic alterations, Parkinsonism symptoms, hyposmia, encephalopathy, and post-COVID-19 syndrome, with potential applications of PET and SPECT in diagnostic work-up related to COVID-19.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series

Aurelie Morand et al.

Summary: Despite lower initial severity at the acute stage of infection, pediatric patients with suspected long COVID showed a similar brain hypometabolic pattern as adult long COVID patients approximately 5 months later, involving bilateral medial temporal lobes, brainstem, cerebellum, and the right olfactory gyrus.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection

Correction Radiology, Nuclear Medicine & Medical Imaging

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study (vol 48, pg 2543, 2021)

Aurelie Kas et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?

E. Guedj et al.

Summary: Several brain complications have been reported in COVID-19 patients, suggesting potential neurotropism and delayed outbreak of neuroinflammatory diseases. PET metabolism analysis showed hypometabolism in the olfactory/rectus gyrus and other brain regions, supporting the neurotropism hypothesis. Further post-viral cohort studies are needed to determine the exact relationship between these hypometabolisms and persistent disorders.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Review Critical Care Medicine

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review

Ghazal Aghagoli et al.

Summary: This review synthesizes the literature on the neurological impact of COVID-19, highlighting potential neurologic manifestations and mechanisms, and emphasizes the importance of understanding and mitigating SARS-CoV-2-associated neurologic injury.

NEUROCRITICAL CARE (2021)

Add to Collection

Article Neurosciences

Neurological Involvements of SARS-CoV2 Infection

Amin Gasmi et al.

Summary: COVID-19, caused by the novel coronavirus SARS-CoV2, is a global pandemic with not only respiratory manifestations but also common CNS involvements. The mechanisms of neuroinvasion by SARS-CoV2 are still unclear.

MOLECULAR NEUROBIOLOGY (2021)

Add to Collection

Article Clinical Neurology

The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning

Gabriel A. de Erausquin et al.

Summary: The impact of SARS-CoV-2 on the central nervous system has raised concerns about the risk of later life cognitive decline, Alzheimer's disease, and other dementia. An international consortium has been formed to study the short and long-term consequences of the virus on the CNS and enroll individuals for evaluations to better understand the underlying biology contributing to AD and dementia.

ALZHEIMERS & DEMENTIA (2021)

Add to Collection

Correction Clinical Neurology

Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management (vol 20, 56, 2020)

Mohamed Kazamel et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell

Maxime Niesen et al.

Summary: This study found that sudden loss of smell in COVID-19 patients is associated with metabolic abnormalities in core olfactory and high-order cortical areas, likely related to processes of deafferentation and lack of olfactory stimulation.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps

Silvia Paola Caminiti et al.

Summary: A well-selected healthy control dataset is essential for accurate voxel-wise analyses of brain metabolism. Different datasets show varying performance in assessing hypometabolism patterns in different patient cohorts, but overall accuracy is high.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG brain PET hypometabolism in patients with long COVID

E. Guedj et al.

Summary: In long COVID patients, brain PET scans showed significant hypometabolism in areas including bilateral rectal/orbital gyrus, temporal lobe, brainstem, and cerebellum. These metabolic abnormalities were associated with more functional complaints such as hyposmia/anosmia, memory/cognitive impairment, pain, and insomnia. The study suggests a potential biomarker value in identifying and monitoring long COVID patients, with implications for the impact of ACE drugs and nasal decongestant spray on brain metabolism.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Neurosciences

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Jenny Meinhardt et al.

Summary: The study demonstrates the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting the virus may enter the CNS through the olfactory mucosa. The virus utilizes the neural-mucosal interface in the olfactory mucosa to penetrate the nervous system, affecting various neuroanatomical areas, including the primary respiratory and cardiovascular control center.

NATURE NEUROSCIENCE (2021)

Add to Collection

Review Clinical Neurology

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

Finja Schweitzer et al.

Summary: Neurological symptoms and complications of COVID-19 range from common nonspecific manifestations like headache and dizziness to less frequent but more severe conditions such as Guillain--Barre syndrome and encephalopathy. Comprehensive work-up including cerebrospinal fluid assessment and neuroimaging is necessary for accurate diagnosis and management.

CURRENT OPINION IN NEUROLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study

Martina Sollini et al.

Summary: The study hypothesized that whole-body [18F]FDG-PET/CT could provide insight into the pathophysiology of long COVID. Results revealed increased [18F]FDG uptake in various organs of long COVID patients, suggesting underlying systemic inflammation. Brain hypometabolism patterns were associated with persistent symptoms, indicating different temporal sequences of brain and whole-body inflammatory changes. Whole-body [18F]FDG PET was found to hold potential value in disclosing the pathophysiology of long COVID.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Review Virology

18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations

Thorsten Rudroff et al.

Summary: Scientific evidence on the subacute and long-term effects of COVID-19 caused by SARS-CoV-2 infection is increasing. The infection is systemic and involves multiple organs, leading to diverse complications and long-term consequences. While a significant proportion of patients experience neurological manifestations, the exact brain and skeletal muscle changes from SARS-CoV-2 infection remain largely unknown.

VIRUSES-BASEL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection

Maria Isabella Donegani et al.

Summary: This study identified cortical hypometabolism in patients with isolated persistent hyposmia after SARS-CoV2 infection using [F-18]-FDG PET, and highlighted the involvement of bilateral longitudinal fasciculi in the structural connectivity of these regions.

BIOMEDICINES (2021)

Add to Collection

Article Clinical Neurology

COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital

Kiran T. Thakur et al.

Summary: Many patients with SARS-CoV-2 infection exhibit neurological signs and symptoms, but autopsy results show that most brains have low levels of detectable virus and it does not correlate with the histopathological alterations.

BRAIN (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients

Ganna Blazhenets et al.

Summary: Cognitive impairment in COVID-19 patients can be related to cortical hypometabolism, which shows reversibility after 6 months. Despite significant recovery, residual impairments remain in some patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses

Jacob K. Files et al.

Summary: Patients with prolonged post-COVID-19 symptom duration exhibit maintained SARS-CoV-2-specific immune responses, including antigen-specific T cell responses and increased IgG avidity to the virus, suggesting the persistence of viral antigens as a possible cause for the ongoing symptoms.

JCI INSIGHT (2021)

Add to Collection

Review Clinical Neurology

Neurological Symptoms, Comorbidities, and Complications of COVID-19: A Literature Review and Meta-Analysis of Observational Studies

Kimia Vakili et al.

Summary: The most prevalent neurological symptoms of COVID-19 include fatigue, gustatory dysfunction, anorexia, olfactory dysfunction, headache, dizziness, and nausea. Cerebrovascular disease is the most common neurological comorbidity in COVID-19.

EUROPEAN NEUROLOGY (2021)

Add to Collection

Letter Radiology, Nuclear Medicine & Medical Imaging

18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19

Mahboobeh Karimi-Galougahi et al.

ACADEMIC RADIOLOGY (2020)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

COVID-19 pandemic: guidance for nuclear medicine departments

D. Paez et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection

Review Clinical Neurology

Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients

Yassine Yachou et al.

NEUROLOGICAL SCIENCES (2020)

Add to Collection

Article Clinical Neurology

COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings

C. Delorme et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Review Anatomy & Morphology

Neuromechanisms of SARS-CoV-2: A Review

Marcos F. DosSantos et al.

FRONTIERS IN NEUROANATOMY (2020)

Add to Collection

Article Clinical Neurology

Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)

Rosalie V. Kogan et al.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners

Luca Presotto et al.

NEUROINFORMATICS (2017)

Add to Collection

Article Computer Science, Interdisciplinary Applications

A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia

Pasquale Anthony Della Rosa et al.

NEUROINFORMATICS (2014)

Add to Collection

Article Neuroimaging

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting

Daniela Perani et al.

NEUROIMAGE-CLINICAL (2014)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

EANM procedure guidelines for PET brain imaging using [F-18]FDG, version 2

Andrea Varrone et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.